NO325059B1 - Fremgangsmate ved fremstilling av 4-(des-dimetylamino)-tetracykliner - Google Patents
Fremgangsmate ved fremstilling av 4-(des-dimetylamino)-tetracykliner Download PDFInfo
- Publication number
- NO325059B1 NO325059B1 NO19992072A NO992072A NO325059B1 NO 325059 B1 NO325059 B1 NO 325059B1 NO 19992072 A NO19992072 A NO 19992072A NO 992072 A NO992072 A NO 992072A NO 325059 B1 NO325059 B1 NO 325059B1
- Authority
- NO
- Norway
- Prior art keywords
- tetracyclines
- des
- dimethylamino
- tetracycline
- reduction
- Prior art date
Links
- 239000004098 Tetracycline Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 24
- 229940040944 tetracyclines Drugs 0.000 title claims abstract description 19
- 230000008569 process Effects 0.000 title claims abstract description 5
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 235000019364 tetracycline Nutrition 0.000 claims abstract description 32
- 150000003522 tetracyclines Chemical class 0.000 claims abstract description 31
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000003792 electrolyte Substances 0.000 claims abstract description 5
- 230000002378 acidificating effect Effects 0.000 claims abstract description 4
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 41
- 229960002180 tetracycline Drugs 0.000 claims description 17
- 229930101283 tetracycline Natural products 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 15
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000001103 potassium chloride Substances 0.000 claims description 6
- 235000011164 potassium chloride Nutrition 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 4
- 229910052753 mercury Inorganic materials 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 239000003929 acidic solution Substances 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 235000007715 potassium iodide Nutrition 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 235000009518 sodium iodide Nutrition 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 13
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 239000012022 methylating agents Substances 0.000 abstract description 2
- 238000005868 electrolysis reaction Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 12
- 239000011701 zinc Substances 0.000 description 12
- 229910052725 zinc Inorganic materials 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940075397 calomel Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- -1 isopropyl ether Chemical compound 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- ZXFCRFYULUUSDW-UHFFFAOYSA-N C1C2CC3=CC=CC(O)=C3C(=O)C2=C(O)C2(O)C1CC(O)=C(C(=O)N)C2=O Chemical compound C1C2CC3=CC=CC(O)=C3C(=O)C2=C(O)C2(O)C1CC(O)=C(C(=O)N)C2=O ZXFCRFYULUUSDW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/24—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT102160A PT102160B (pt) | 1998-05-26 | 1998-05-26 | Processo para a preparacao de 4-(des-dimetilamino)-tetraciclinas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO992072D0 NO992072D0 (no) | 1999-04-29 |
| NO992072L NO992072L (no) | 1999-11-29 |
| NO325059B1 true NO325059B1 (no) | 2008-01-21 |
Family
ID=20085765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19992072A NO325059B1 (no) | 1998-05-26 | 1999-04-29 | Fremgangsmate ved fremstilling av 4-(des-dimetylamino)-tetracykliner |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6143161A (zh) |
| EP (1) | EP0962552B1 (zh) |
| JP (1) | JP2000034264A (zh) |
| KR (1) | KR19990087905A (zh) |
| CN (1) | CN1192016C (zh) |
| AT (1) | ATE213788T1 (zh) |
| AU (1) | AU746608B2 (zh) |
| CA (1) | CA2272598C (zh) |
| DE (1) | DE69900927T2 (zh) |
| ES (1) | ES2173706T3 (zh) |
| HU (1) | HUP9900761A3 (zh) |
| IL (1) | IL129244A (zh) |
| IN (1) | IN192877B (zh) |
| NO (1) | NO325059B1 (zh) |
| NZ (1) | NZ334940A (zh) |
| PT (1) | PT102160B (zh) |
| ZA (1) | ZA992484B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101171408B1 (ko) | 2004-05-21 | 2012-08-08 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 테트라사이클린 및 이의 유사체의 합성 |
| JP5335664B2 (ja) * | 2006-04-07 | 2013-11-06 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | テトラサイクリンおよびその類似体の合成 |
| EP2487160B1 (en) | 2006-10-11 | 2016-02-03 | President and Fellows of Harvard College | Synthesis of Enone Intermediate |
| WO2010126607A2 (en) | 2009-04-30 | 2010-11-04 | President And Fellows Of Harvard College | Synthesis of tetracyclines and intermediates thereto |
| PT108978B (pt) | 2015-11-24 | 2020-03-09 | Hovione Farm S A | Sais de tetraciclinas |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1349043A (en) * | 1971-04-05 | 1974-03-27 | Pliva Pharm & Chem Works | Process for the preparation of 6-demethyl-6-deoxy-6-methylene tetracyclines |
| US5308839A (en) * | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| JP3016587B2 (ja) * | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
| US5223248A (en) * | 1991-02-11 | 1993-06-29 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing antiplaque properties |
| CA2094874C (en) * | 1992-04-27 | 2003-02-11 | Thomas F. Mcnamara | Non-antibacterial tetracycline compositons possessing antiplaque properties |
| JPH069523A (ja) * | 1992-06-18 | 1994-01-18 | Kuraray Co Ltd | ４−デジメチルアミノテトラサイクリンの精製法 |
| EP0599397B1 (en) * | 1992-11-17 | 1996-08-28 | The Research Foundation Of State University Of New York | Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes |
| US5552297A (en) * | 1993-12-21 | 1996-09-03 | Abbott Laboratories | Lead detection method and reggents utilizing aminolevulinic acid dehydratase and tertiary phosphines |
| US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
-
1998
- 1998-05-26 PT PT102160A patent/PT102160B/pt not_active IP Right Cessation
-
1999
- 1999-03-25 HU HU9900761A patent/HUP9900761A3/hu unknown
- 1999-03-26 AU AU22444/99A patent/AU746608B2/en not_active Ceased
- 1999-03-30 IL IL12924499A patent/IL129244A/xx not_active IP Right Cessation
- 1999-03-30 NZ NZ334940A patent/NZ334940A/xx unknown
- 1999-03-31 ZA ZA9902484A patent/ZA992484B/xx unknown
- 1999-04-01 EP EP99302600A patent/EP0962552B1/en not_active Expired - Lifetime
- 1999-04-01 ES ES99302600T patent/ES2173706T3/es not_active Expired - Lifetime
- 1999-04-01 DE DE69900927T patent/DE69900927T2/de not_active Expired - Lifetime
- 1999-04-01 AT AT99302600T patent/ATE213788T1/de active
- 1999-04-09 IN IN555DE1999 patent/IN192877B/en unknown
- 1999-04-09 KR KR1019990012481A patent/KR19990087905A/ko not_active Application Discontinuation
- 1999-04-13 JP JP11105105A patent/JP2000034264A/ja active Pending
- 1999-04-21 CN CNB991051548A patent/CN1192016C/zh not_active Expired - Fee Related
- 1999-04-29 NO NO19992072A patent/NO325059B1/no not_active IP Right Cessation
- 1999-05-21 CA CA002272598A patent/CA2272598C/en not_active Expired - Fee Related
- 1999-05-24 US US09/317,396 patent/US6143161A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000034264A (ja) | 2000-02-02 |
| US6143161A (en) | 2000-11-07 |
| EP0962552A1 (en) | 1999-12-08 |
| IN192877B (zh) | 2004-05-29 |
| NO992072L (no) | 1999-11-29 |
| CA2272598C (en) | 2008-01-22 |
| CN1236775A (zh) | 1999-12-01 |
| PT102160A (pt) | 1999-11-30 |
| DE69900927T2 (de) | 2002-08-29 |
| CN1192016C (zh) | 2005-03-09 |
| PT102160B (pt) | 2001-04-30 |
| AU2244499A (en) | 1999-12-02 |
| IL129244A0 (en) | 2000-02-17 |
| CA2272598A1 (en) | 1999-11-26 |
| ZA992484B (en) | 1999-10-05 |
| HUP9900761A2 (hu) | 1999-12-28 |
| DE69900927D1 (de) | 2002-04-04 |
| EP0962552B1 (en) | 2002-02-27 |
| KR19990087905A (ko) | 1999-12-27 |
| AU746608B2 (en) | 2002-05-02 |
| IL129244A (en) | 2003-01-12 |
| HUP9900761A3 (en) | 2000-06-28 |
| ATE213788T1 (de) | 2002-03-15 |
| ES2173706T3 (es) | 2002-10-16 |
| NZ334940A (en) | 2000-05-26 |
| HU9900761D0 (en) | 1999-05-28 |
| NO992072D0 (no) | 1999-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0518958B1 (pt) | "método para produzir um derivado de biopterina, 1;2'-0- diacetil-l-biopterina e l-biopterina" | |
| NO325059B1 (no) | Fremgangsmate ved fremstilling av 4-(des-dimetylamino)-tetracykliner | |
| US4270994A (en) | Electrochemical dehydrogenation of steroidal Δ3,5 enol ethers under basic conditions to provide steroidal Δ4,6 dienones | |
| JPS6249358B2 (zh) | ||
| SU1493101A3 (ru) | Способ получени п-аминофенола или его производных | |
| MXPA99003858A (es) | Un proceso para la preparacion de 4-(des-dimetilamino)-tetraciclinas | |
| JPS60243293A (ja) | ｍ−ハイドロオキシベンジルアルコ−ルの製造法 | |
| Mengoli et al. | Anodic ethylation of lead by cathodically produced diethylcadmium | |
| Sato et al. | Electron-organic Chemistry. IV. Structure—Anodic Potential Relationship and Electron-transfer-induced Reactions of [2.2] Para-and-Metaparacyclophanes | |
| US4392923A (en) | Process for preparing thiazolinozetidinone derivatives | |
| Ameri et al. | A Facile and Efficient One‐Pot Electrochemical Synthesis of Thiazole Derivatives in Aqueous Solution | |
| SU1456427A1 (ru) | Способ получени 3-морфолинпропиламина | |
| JP2622115B2 (ja) | ベンジルアルコール類の製造方法 | |
| IE61279B1 (en) | Process for the production of salts of aminomalonodinitrile | |
| JPH0230397B2 (zh) | ||
| Hlavatý et al. | Electrochemical reduction of 2, 2'-dinitrophenyl ether and 2, 2'-dinitrodiphenylamine at mercury cathodes | |
| FI74949B (fi) | Framstaellningsfoerfarande foer 6-klor- -metyl-karbazol-2-aettiksyra. lisaeys patenttiin 71130 - tillaegg till patent 71130 | |
| Cristea et al. | Electroreduction of (1 S, 2S)-2-amino-1-(4-nitrophenyl)-propane-1, 3-diol derivatives. Behaviour of electrogenerated species and applications to organic synthesis | |
| JP4113955B2 (ja) | ポリフルオロベンゾキノン類の製造方法 | |
| CN101139726A (zh) | 一种四环素的制作方法 | |
| JPS6018755B2 (ja) | ベンジル酸誘導体の製造方法 | |
| JPS63171889A (ja) | ｍ−置換ベンジルアルコ−ルの製造法 | |
| Khazalpour et al. | Electrochemical Synthesis of New Quinone-Imines with Assisted of 4-Ethynylaniline and Para-Toluidine as Nucleophile | |
| Iversen et al. | ORGANIC ELECTROSYNTHESES VII. CONVENIENT PREPARATION OF p-AMINOBENZYLCYANIDE BY CATHODIC REDUCTION OF p-NITROBENZYLCYANIDE | |
| JPS63206488A (ja) | ｍ−ヒドロキシベンジルアルコ−ルの電解製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |